FOS and epilepsy: In Phase 2, we described the effects of both peptides in two acute models of epilepsy—kainic acid and pentylenetetrazole-induced model of seizures—and measured estimated ED50 and therapeutic index values, electroencephalographic studies and C-fos evaluation.